Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GFRAL is a receptor that mediates the effects of growth differentiation factor 15 (GDF15), particularly in the central nervous system, specifically in the area postrema and nucleus tractus solitarius of the brainstem. Upon binding GDF15, GFRAL forms a complex with RET, activating intracellular pathways that influence metabolic processes, appetite, energy expenditure, and body weight regulation. The GDF15-GFRAL pathway has been implicated in cancer cachexia.
GFRAL antagonistic antibodies are in development; these block GDF15 binding and signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glial cell line-derived neurotrophic factor receptor alpha like.